Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
FDA extends review of Arzerra (ofatumumab)
GlaxoSmithKline, 06/17/09
GlaxoSmithKline and Genmab A/S announced that the United States Food and Drug Administration informed the companies that the agency has extended the action date for the ofatumumab BLA application by three months.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/18/09
Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09
Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09
Article Search
Sponsor


See Latest Articles


